Hemophiliac HCV Plan definition

Hemophiliac HCV Plan means the plan to provide compensation to persons who are Primarily-Infected Hemophiliacs, who received or took Blood (Hemophiliac) during the Class Period and were infected with HCV and their respective HCV Personal Representatives, Secondarily-Infected Persons and Family Members pursuant to provisions of the Settlement Agreement.
Sample 1Sample 2Sample 3
Hemophiliac HCV Plan has the meaning set out in Section 3.02.
Sample 1
Hemophiliac HCV Plan means the plan attached as Schedule B to the Settlement Agreement.
Sample 1

Examples of Hemophiliac HCV Plan in a sentence

  • Although the hourly rate payable in respect of loss of services in the home is expressed at$12 per hour (1999 dollars) under the Transfused HCV Plan and the Hemophiliac HCV Plan and as $16.15 per hour (2014 dollars) for the special distribution benefits under the 2016 Allocation Orders and the HCV Late Claims Benefit Plan, in all cases the hourly rate payable is indexed to the dollar value at the time the payment is actually made.

  • An amount not to exceed $5,000 to reimburse uninsured funeral expenses may be payable to the Approved HCV Personal Representative or Approved Late Claim HCV Personal Representative on behalf of the estate of the HCV Infected Person who has died, pursuant to section 5.01(2) of the Transfused HCV Plan or the Hemophiliac HCV Plan.

  • The Transfused HCV Plan and the Hemophiliac HCV Plan provide for a maximum recovery of 20 hours per week of loss of services in the home and the special distribution benefits under the 2016 Allocation Orders provide for a maximum recovery of 2 additional hours.

  • In keeping with the directions of the Courts, this HCV Late Claims Benefit Plan is intended to provide benefits to Approved Late Claim Class Members that are not better or different than the benefits provided to Approved Transfused/Hemophiliac Plan Class Members under the Settlement Agreement by means of the Transfused HCV Plan, the Hemophiliac HCV Plan and the HCV Special Distribution Benefits.

  • If the courts do not make an order permitting such re-elections, than this proposed amendment is moot.2This proposed amendment corresponds with the Joint Committee’s proposal to allow class members to reverse an election made pursuant to s.4.08 of the Hemophiliac HCV Plan or s.4.08(Hemo) of the HCV Late Claims Benefit Plan.

  • When the Settlement Agreement was approved, the courts ordered that persons with Thalassemia Major would be subjected to the proof requirements and benefits under the Hemophiliac HCV Plan except section 4.01(5) of that Plan.

  • Subject to certain specified exceptions in the Transfused HCV Plan and the Hemophiliac HCV Plan established by the Settlement Agreement and in the court approved protocols implemented for those plans, Transfused/Hemophiliac Plan Claims by Class Members were to be made on or before June 30, 2010.

  • Currently, there are 13 court approved protocols which provide direction to the Administrator on reviewing and assessing the claims brought pursuant to the Transfused HCV Plan and the Hemophiliac HCV Plan.

  • The existing court approved protocols were drafted at different times and they do not all use a consistent style nor always make use of the definitions in the Settlement Agreement, the Transfused HCV Plan and the Hemophiliac HCV Plan.

  • Strosberg, Q.C., counsel in action 98-CV-141369 and one of the Ontario court-appointed members of the Joint Committee, with all aspects of this action and the implementation and ongoing supervision of the 1986-1990 Hepatitis C Settlement Agreement including the Transfused HCV Plan and the Hemophiliac HCV Plan.

Related to Hemophiliac HCV Plan

  • haemophilia means an inheritable disease, usually affecting only male but transmitted by women to their male children, characterised by loss or impairment of the normal clotting ability of blood so that a minor would may result in fatal bleeding;

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • HIV means human immunodeficiency virus.

  • Participating Home Infusion Therapy Provider means a Home Infusion Therapy Provider who has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Treatment program means an abstinence based program or facility that is accredited by any of the following:

  • Non-Participating Home Infusion Therapy Provider means a Home Infusion Therapy Provider who does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • inherited metabolic disease means a disease caused by an inherited abnormality of body chemistry for which testing is mandated by law;

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.

  • Iatrogenic infertility means an impairment of fertility by surgery, radiation, chemotherapy, or other medical treatment affecting reproductive organs or processes.

  • Dental laboratory means a person, firm or corporation

  • Opioid treatment program means a detoxification or maintenance treatment program which is required to report patient identifying information to the central registry and which is located in the state.

  • Therapeutically equivalent drug products means drug products that contain the same active ingredients and are identical in strength or concentration, dosage form, and route of administration and that are classified as being therapeutically equivalent by the U.S. Food and Drug Administration pursuant to the definition of "therapeutically equivalent drug products" set forth in the most recent edition of the Approved Drug Products with Therapeutic Equivalence Evaluations, otherwise known as the "Orange Book."

  • Participating Retail Health Clinic means a Retail Health Clinic which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Pump spray means a packaging system in which the product ingredients within the container are not under pressure and in which the product is expelled only while a pumping action is applied to a button, trigger or other actuator.

  • Treatment plan means a written agreement between the department and the parent or

  • COVID-19 Pandemic means the SARS-Cov2 or COVID-19 pandemic, including any resurgence or evolutions or mutations thereof and/or any related or associated outbreaks, epidemics and/or pandemics.

  • Transplant hospital means a hospital that furnishes organ transplants and other medical and surgical specialty services required for the care of transplant patients.

  • Anabolic steroid means any drug or hormonal substance, chemically and pharmacologically related

  • Cardiopulmonary resuscitation or "CPR" means artificial ventilation or external

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Medical cannabis card means the same as that term is defined in Section 26-61a-102.

  • Community mental health program means all mental health

  • Adolescent means a Medicaid patient 17 years or younger.

  • Medical cannabis means the same as that term is defined in Section 26-61a-102.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;